Sansan proves business cards aren’t dead with $17m funding

JapanTech in Asia — Business cards aren’t dead, they’re just evolving. That’s the premise behind Sansan, a startup that digitizes the woodpulpy rectangles we can’t quite seem to get rid of, and creates contact databases in the cloud for corporate users. Sansan has just received a strong validation for its business, announcing today it has raised a series C round worth S$24.2 million (US$16.8 million).

Startup raises S$24.2m to help more Singapore companies use the cloud

JapanBusiness Times — SANSAN, a cloud startup that digitises business cards for collaborative use within companies, has raised S$24.2 million in Series C funding – S$4.2 million of which will be invested in Singapore to help more businesses here use the cloud to boost productivity.

Sansan unveils new Singapore office

SingaporeMIS Asia — Japan-based cloud-based contact management services provider, Sansan, has expanded its footprint in the Asia Pacific market with a new office in Singapore. The Singapore presence of Sansan will be under the new entity called Sansan Global Pte Ltd, supporting its growth across Asia Pacific and increasing its ability to help business enterprises digitise their business contacts and enhance the way of doing business.

This Japanese startup has 14 million reasons why the business card isn’t dead

Thanks to the rise of social networks and smartphones, business cards don’t quite hold the same cachet that they used to. In Western markets, some people refuse to carry more than one card to networking events (lest they appear desperate), while others proclaim that the age of the business card is flat-out over. For professionals across Asia, however, the humble business card remains a vital tool for introductions and a jumping-off point for future networking.

Too many business cards? Japan’s Sansan gets $14 million to bring its cloud-based contact manager to the US

Sansan, a Japanese startup that specializes in scanning and storing business card details, has secured US$14 million in funding led by Silicon Valley investment firm DCM. A leader in its field in Japan, the company will now use the money to launch its product in the US and extend its reach in Asia.